Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 28, 2011 02:30 ET | Source: Mertiva

Publication of change in the total number of shares and votes in Diamyd Medical AB

Publication of change in the total number of shares and votes in Diamyd Medical AB As of February 28, 2011, the share capital in Diamyd Medical AB (publ.) is 14,764,706.50 SEK. The total number of...
February 28, 2011 02:30 ET | Source: Mertiva

Offentliggörande av förändring av det totala antalet aktier och röster i Diamyd Medical AB

Offentliggörande av förändring av det totala antalet aktier och röster i Diamyd Medical AB Per den 28 februari 2011 uppgår aktiekapitalet i Diamyd Medical AB (publ.) till 14 764 706,50 kronor. Det...
February 14, 2011 02:30 ET | Source: Mertiva

Sista patienten fullbordar europeisk fas III-studie med den antigenbaserade terapin Diamyd® för typ 1-diabetes

Sista patienten fullbordar europeisk fas III-studie med den antigenbaserade terapin Diamyd® för typ 1-diabetes Den sista patienten har gjort sitt 15-månadersbesök i Diamyd Medicals europeiska fas...
February 14, 2011 02:30 ET | Source: Mertiva

Last patient completes the EU Phase III study of Diamyd® antigen based therapy for type 1 diabetes

Last patient completes the EU Phase III study of Diamyd® antigen based therapy for type 1 diabetes The final patient has performed the last visit of the main study period in Diamyd Medical's European...
February 11, 2011 07:00 ET | Source: Mertiva

University of Florida Research Foundation initiates court case

University of Florida Research Foundation initiates court case The University of Florida Research Foundation Inc. (UFRF) has filed a lawsuit in United States federal district court in Florida...
February 11, 2011 07:00 ET | Source: Mertiva

University of Florida Research Foundation inleder rättsprocess

University of Florida Research Foundation inleder rättsprocess University of Florida Research Foundation Inc. (UFRF) har inkommit med en stämningsansökan till United States Federal District Court i...
February 10, 2011 03:48 ET | Source: Mertiva

Diamyd Phase II study in cancer pain posted on ClinicalTrials.gov

Diamyd Phase II study in cancer pain posted on ClinicalTrials.gov Diamyd Medical´s US Phase II clinical trial, evaluating the ability of the candidate drug NP2 Enkephalin to reduce cancer pain, is...
February 10, 2011 03:48 ET | Source: Mertiva

Diamyds fas II-studie i cancersmärta listad på ClinicalTrials.gov

Diamyds fas II-studie i cancersmärta listad på ClinicalTrials.gov Diamyd Medicals amerikanska fas II-studie med syfte att testa läkemedelskandidaten NP2 Enkefalins potential att lindra...
January 25, 2011 02:31 ET | Source: Mertiva

Diamyd expects to begin reporting Phase III results in late spring 2011

Diamyd expects to begin reporting Phase III results in late spring 2011 Diamyd Medical's President and CEO Elisabeth Lindner states in the CEO comments in today's quarterly report that the Company...
January 25, 2011 02:31 ET | Source: Mertiva

Diamyd beräknar börja rapportera fas III-resultat under senvåren 2011

Diamyd beräknar börja rapportera fas III-resultat under senvåren 2011 Diamyd Medicals vd och koncernchef Elisabeth Lindner meddelar i vd-ordet i dagens delårsrapport att resultat från bolagets...